Objective To evaluate the association between nutrition delivery practices and energy and protein intake during the transition from parenteral to enteral nutrition in infants of very low birth weight (VLBW).
D
espite the recognized importance of sufficient protein and energy intake for infants who are very low birth weight (VLBW), deficits in intake over the first postnatal weeks are well documented. [1] [2] [3] The transition from parenteral nutrition (PN) to enteral nutrition is associated with a decrease in protein intake and results in a decline in growth velocity. 4 Earlier establishment of full enteral nutrition, suggesting a shortened transition period, is associated with improved growth velocity in infants who are VLBW. 5 The transition from full parenteral fluids to enteral nutrition requires decisions about modifiable nutrition delivery practices, including PN, intravenous lipids, vascular access, feeding fortification, and total fluid volume. 2, 4, 6, 7 For instance, decisions about the removal of central-line vascular access through which highly concentrated PN is delivered are influenced by efforts to reduce central line-associated blood-stream infections, 8, 9 and decisions about total fluid volume can be affected by the cardiopulmonary status of infants with VLBW. 7, 10 Although each decision in isolation affects the quality and quantity of nutrition delivered, the cumulative role of these decisions about nutrition delivery practices has not been delineated. Quantifying the effect of these decisions could offer potential interventions to improve nutrition delivery.
The aim of this study was to evaluate the association between nutrition delivery practices on energy and protein intake during the transition from PN to enteral nutrition in infants who were VLBW. We hypothesized that these nutrition delivery practices significantly affect the nutrients delivered and that the magnitude of their effect changes during the transition from PN to enteral nutrition. care unit (NICU) were identified through the Children's Hospitals Neonatal Database. 11 Infants admitted within the first week of life and discharged after the first month of life were included; infants with chromosomal abnormalities or congenital anomalies were excluded because of the uncertain influence these conditions may have had on metabolism and growth.
Methods
Infant characteristics were identified through the Children's Hospitals Neonatal Database and included receipt of antenatal steroids, birth weight, gestational age, sex, ages at admission and discharge. Comorbid conditions included patent ductus arteriosus, necrotizing enterocolitis or spontaneous intestinal perforation (NEC/SIP), intubation on day 28, small for gestational age, and birth to discharge growth velocities for weight, length, and head circumference. 3 Growth velocity was calculated via the exponential method and reported in g/kg/d 12 ; length and head circumference were reported in mm/wk. 13 Nutrition standards during the study period included the administration of PN as a mixture of parenteral protein, dextrose, and added components immediately on admission to the NICU. Intravenous lipids and minimal enteral feedings typically were initiated within 72 hours of admission and advanced to a goal of 150-160 mL/kg/d at the clinician's discretion. Human milk feedings were fortified with a bovine milkbased fortifier, most commonly after reaching 100 mL/kg/d. The timing of fortification initiation and PN and intravenous lipids discontinuation was at the discretion of the neonatologist.
In 2013, a change in standard practice occurred for PN orders. Before March 26, 2013, PN volumes were ordered at the nil per os (NPO, ie, nothing by mouth) rate, regardless of enteral feeding status. For example, an infant prescribed a total fluid volume of 150 mL/kg/d with 60 mL/kg/d from enteral nutrition would still have 150 mL/kg/d of PN ordered. After March 26, 2013, PN was ordered at the intended rate, such that the volume ordered took into account the anticipated enteral nutrition volume during the next 24-hour period. In the aforementioned example, only 90 mL/kg/d of PN would have been ordered. No other practices for enteral nutrition or PN were systematically changed during the study period.
Actual intake of parenteral fluids and enteral nutrition was abstracted from the medical record at the patient-day level through the first 6 weeks of life. 3 This time frame was chosen because it is the period during which most infants transition from parenteral fluids to full enteral nutrition. The following variables were extracted: total fluid volume (milliliters); details of enteral nutrition including enteral feeding type, feeding volume, and concentrations of feeding fortification; details of PN including daily doses of dextrose, protein, and lipids; and individual volumes of all parenteral infusions. Energy and macronutrient intake were calculated using published reference values for formulas and fortification. 14, 15 Unfortified human milk was assumed to have 67.6 kcal/dL and 1.03 g/dL of protein, 4.38 g/dL of fat, and 6.89 g/dL of carbohydrate. 16, 17 The caloric content of parenteral protein, fat, and carbohydrate was assumed to be 4, 10, and 3.4 kcal/g, respectively.
18 Energy and protein intake were normalized to daily weight and described in units of kcal/kg/d and g/kg/d, respectively. Total fluid intake for each patient day was normalized to daily weight (mL/kg/d) and categorized as nutritive or non-nutritive. Nutritive fluid intake was determined by adding administered volumes of PN, intravenous lipid, non-PN intravenous dextrose, and enteral feedings. Non-nutritive fluid intake included medications administered as continuous infusions, boluses, and flushes. Non-nutritive fluids containing dextrose (eg, fentanyl in 5% dextrose solution) were included in energy calculations.
Five, mutually exclusive phases of nutrition were defined by the proportion of nutritive fluids provided through the enteral route: phase 1 (0%; NPO), phase 2 (>0, ≤33.3%), phase 3 (>33.3, ≤66.7%), phase 4 (>66.7, <100%), and phase 5 (100%; full enteral nutrition). The distribution over all patient-days was U-shaped. Therefore, for the analysis, 3 phases (2, 3, and 4) were considered to be the transition period to minimize assumptions (eg, energy and protein intake remained the same throughout the transition) without introducing complexity.
Definitions of nutrition delivery practices include: PN at the NPO rate (any PN ordered before March 26, 2013) as opposed to PN at the intended rate, intravenous lipids, presence of a central line, fortified feedings (average daily concentration of enteral feeds ≥24 kcal/oz), total fluid restriction (≤130 mL/ kg/d), and excess non-nutritive fluid intake (>10 mL/kg/d). Fluid restriction and excess non-nutritive fluid intake determinations were chosen because for about 25% of patientdays, infants received less than or equal to 130 mL/kg/d, and for about 25% of patient-days, infants received greater than 10 mL/kg/d of non-nutritive fluids. These values also were associated with less than 100 kcal/kg/d of energy intake ( Table I ; available at www.jpeds.com).
Statistical Analyses
For each phase, the number of patient-days, median and IQR for energy, protein, and fluid intake were calculated. Energy, protein, and fluid intake for phases 1-4 were compared with phase 5 (reference category). All statistical comparisons were conducted at the patient-day level and used mixed-effects linear regression to account for repeated measures in the same infant. 19 Beta coefficients with 95% CIs are reported in kcal/kg/d or g/kg/d of protein. Two-tailed tests, with P < .05, defined statistical significance. The median parenteral, enteral, and combined energy and protein intakes were graphed by phase of nutrition. The proportion of infants in each phase of nutrition was graphed by age.
Bivariable analyses determined significant associations between discrete nutrition delivery practices and energy or protein intake. PN at the NPO and at the intended rate were included in the same models with a reference group of "none." The definitions of the 5 phases precluded analyses of fortification in phase 1 and of PN and intravenous lipids in phase 5 (nonapplicable). Analyses between intravenous lipids and protein intake were not performed on the basis that intravenous lipids contain no protein. Energy and protein intake were Volume 202 • November 2018 the sum of parenteral and enteral intake. Therefore, during phases 2, 3, and 4, bivariable analyses were performed between nutrition delivery practices and parenteral energy or protein intake, and enteral energy or protein intake. Unless otherwise specified, energy and protein intake refer to the combined parenteral and enteral intake.
Ten multivariable models described energy and protein intake in the 5 phases. These equations were developed using backward stepwise reduction with a model entry criterion of P < .20. Analyses were adjusted for birth weight and comorbid conditions, as they may affect energy and protein intake, when these adjustments met entry criterion. Collinearity was assessed using variance inflation factors for all final models.
Results
Detailed nutritional and fluid data were obtained on 115 infants over 4643 patient-days with a median observation period of 42 (IQR 41, 42) days per patient. Median infant gestational age and birth weight were 28.0 weeks (IQR 25.4, 30.1) and 1060 g (IQR 750, 1300), respectively. In total, 48% of infants were female; 50% were born to mothers who received antenatal steroids, and 82% were admitted by day 1. Patent ductus arteriosus, NEC/SIP, intubation on day 28, and small for gestational age status were present in 48%, 18%, 35%, and 11%, respectively. Among those affected by NEC/SIP, one-half (11/ 21) were diagnosed before admission. Median growth velocities in weight, length, and head circumference were 12.2 g/kg/d (IQR 10.7, 13.4), 8.6 mm/wk (IQR 7.3, 9.7), and 6.9 mm/wk (IQR: 5.9, 7.8), respectively.
The transition period accounted for 39% of all patientdays during the study period (Table II ; available at www.jpeds.com). The differences in energy intake between phases 1 through 4 and phase 5 were statistically and clinically significant. Protein intake declined in phases 3 and 4, and these phases were associated with decreased protein intake compared with phase 5. Fluid intake was greatest in phase 5, with a median intake of 150 mL/kg/d. The median energy and protein intake from parenteral, enteral, and combined sources are noted in Figure 1 . The proportion of infants in each phase throughout the 6 weeks are described in Figure 2 (available at www.jpeds.com). Of note, 51% and 73% of infants reached phase 5 by days 21 and 42, respectively. Table III describes the results of the bivariable analyses of nutrition delivery practices on energy and protein intake during each phase of nutrition. PN and the presence of a central line were associated with increased energy and protein intake during phases 1, 2, 3, and 4. Intravenous lipids also were associated with increased energy intake. During the transition period, these nutrition delivery practices were associated with increased parenteral energy and protein intake and clinically smaller changes in enteral energy and protein intake (data not shown). Fluid restriction was associated with decreased energy and protein intake, and excess non-nutritive fluid was associated with decreased energy intake.
In the unadjusted analyses, fortification was associated with decreased energy and protein intake in phases 2 and 3 but For each phase, multivariable models depict the relative tradeoffs in energy and protein intake associated with nutrition delivery practices (Table IV) Findings in the multivariable models were similar to the bivariable analyses with notable exceptions. PN at both NPO and intended rates was not associated with energy intake in phase 4. Throughout the transition period, PN at the intended rate was associated with greater protein intake than at the NPO rate. Fortification was associated independently with increased energy intake in phases 4 and 5 and protein intake during phases 3, 4, and 5. Fortification was no longer associated with decreased energy or protein intake.
To address the findings noted with fortification in the unadjusted analysis, infant days with fortification in phases 2 and 3 were compared with infant days without fortification. Infant days with fortification were less likely to have a central line or receive PN after adjusting for remaining practices and total fluid intake. Infant days with fortification also were associated with less parenteral protein (in infants receiving PN), less parenteral fat (in infants receiving intravenous lipids), and less parenteral carbohydrates (data not shown).
Discussion
We describe the association between nutrition delivery practices and energy and protein intake in infants who were VLBW during the transition from parenteral fluids to full enteral nutrition. The models quantify the trade-offs that need to be considered for each nutrition delivery practice decision. Although PN, intravenous lipids, fortification, and fluid intake vary in concentration and/or volume, they were analyzed dichotomously to simplify the complexity of the trade-offs and because clinicians appear to approach such decisions in a dichotomous manner (eg, should we continue PN today?). The complexity of balancing such trade-offs is highly relevant for infants who are VLBW in the immediate postnatal period and infants made NPO for feeding intolerance or evaluation and management of NEC/SIP. 20 The findings of this study suggest the following recommendations to maximize energy and protein intake in VLBW infants: (1) deliver PN and intravenous lipids through phase 3 (≤66.7% enteral) to maximize energy intake; (2) consider PN through phase 4 (<100% enteral) to maximize protein intake; (3) deliver PN preferably through a central line; (4) order PN at the intended not NPO rate; (5) discontinue the central line in an infant before phase 5 (full enteral feeds) whenever possible; (6) initiate fortification in phase 3 (>33.3% enteral) to maximize protein intake; and (7) limit fluid restriction and excess non-nutritive fluid intake whenever possible. We acknowledge that our suggested approaches prioritize nutrient delivery and are not ideal for competing interests such as the reduction of central-line use.
The paradoxical results of fortification in the bivariable and multivariable analyses during phases 2 and 3 were surprising. Infants fortified in phases 2 and 3 received less energy and protein. Gains in enteral energy and protein appear to be negated by larger losses of parenteral energy and protein delivery. These losses are expected to be clinically significant, given that our previous work demonstrated that an increased energy intake of 10 kcal/kg/d over the course of the week was associated with an increased growth velocity of 1.7 g/kg/d. 3 The transition phases from parenteral to full enteral feeds represent a dynamic time when energy and protein contribution from each nutrition delivery practice changes. Ideally, clinicians would have easy access to real-time data assessing the energy and protein intake actually received and projected to receive from orders 21 ; however, such a data infrastructure is not widely available. 22, 23 Even though calculating energy and protein intake does not require advanced mathematics, retrieval of the data to assess the gain or loss in energy and protein from each nutrition delivery practice requires time and effort.
This study suggests that an accurate, automated system to compare and contrast the tradeoffs in energy and protein intake with different nutrition delivery practice decisions could substantially assist clinicians. The study attempted to model these scenarios to help guide clinicians; however, real-time feedback from orders placed within the electronic health record would be optimal. As clinicians attempt to reduce central lineassociated infections, early removal of a central line becomes a priority, but without the ability to immediately assess the reduction in energy and protein from the loss of concentrated PN and intravenous dextrose. Similarly, although substantial fluid restriction may be prescribed for bronchopulmonary dysplasia, 10 lack of immediate feedback to the clinical team masks its association on receipt of energy and protein.
There are several limitations to the analysis. This is a retrospective analysis at a single, referral NICU. Nutrition delivery practices for starting or adjusting PN, feedings or fortification, and their associated outcomes may not be generalizable to all NICUs. The sample size included all infants who were VLBW admitted by 1 week without congenital anomalies to minimize selection bias; however, the findings may not be generalizable to other types of infants in the NICU as a result. Published values were used for the caloric and protein content of human milk, yet these also are known to vary by woman and progression of lactation. 24 Documentation errors may have influenced the observed findings: however, daily surveillance of the medical record likely mitigated this limitation and nonsensical differences were reconciled. Lastly, other unknown or unmeasured clinical variables may have affected our results.
In conclusion, achieving recommended nutrient intake for infants who are VLBW during the transition from parenteral to enteral nutrition may be hindered by the dynamic association between nutrition delivery practices and energy and protein intake. We speculate that, without more substantive data and computational infrastructure, clinicians are unlikely to be able to accurately ascertain the net association on nutrient intake, resulting from the multiple decisions about nutrition delivery practices. Increased recognition of this important deficit should shift attention and resources to the development and implementation of data and computational infrastructure to facilitate nutritional management of infants who are VLBW. Future research needs to examine optimization of the workflow related to data and computation about nutrition delivery practices by clinicians and the potential association on nutrient intake, as well as specification of the software needed to effectively leverage data in the electronic health record. ■ Values represent actual intake, not prescribed. All statistical comparisons were P < .001 unless noted. *Signifies P > .05.
